Levitas Bio announced it raised $11.8 Million in an initial filing from an offering of $25.1 Million

Company

Location

About

LevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular processing and characterization. Our disruptive levitation technology overcomes current technological limitations by providing a gentle, simple and label-free method of isolating specific cell populations. The LeviCell platform enables studies and beneficial uses of previously inaccessible, high-value primary samples and sensitive cell types, regardless of the starting cell number, viability, or sensitivity to processing.